United Health Products develops, manufactures, and markets innovative products based on our proprietary hemostatic gauze technology. Our products are distributed under the brand name HemoStyp®, and other private label names, to the wound care, dental, dialysis, and veterinary markets.

We are customer driven. We distribute both nationally and internationally and support our customers with products and ideas that will enhance their ability to improve the health and care of the people they serve. Our company is based in Westbury, NY and our common stock trades on NASDAQ under the symbol “UEEC.”

HemoStyp® is bio-absorbable sterile gauze that will produce hemostasis almost instantly when applied to a cut or open wound. It is a patented hemostatic agent registered with the FDA to help control bleeding from open wounds.

HemoStyp® contains no harmful chemicals, additives, or animal by-products and is easily removed from the wound with water or saline solution without compromising coagulation.

HemoStyp® is available in multiple sizes and configurations to help control most types of bleeding including: abrasions, lacerations, and major cuts; nose bleeds; dental surgeries; post dialysis treatment; and puncture wounds.

United Health Products Inc. to Present at 24th Annual Wall Street Analyst Forum Institutional Investor Conference on March 3rd in New York City
United Health Products, Inc. a developer and marketer of wound care products and technologies in the healthcare sector, announced that Douglas Beplate, COO, will present at the 24th Annual Wall Street Analyst Forum Institutional Investor Conference on Monday, March 3rd at 12:50pm EDT...
United Health Products Receives Notice of Allowance for Patent Application for HemoStyp® Gauze Product
United Health Products, Inc. (OTCQB: UEEC.PK) announced that it has received formal notification of allowance of its patent application from the U.S. Patent Office for its hemostatic gauze product, HemoStyp®, and that the patent will issue shortly.